Open AccessHigh Progesterone levels in the beginning of ICSI antagonist cycles and clinical pregnancy: still a concern?
Author(s) -
Tatiana R Panaino,
Joyce B da Silva,
Maria Augusta T de Lima,
Paloma Lira,
Patrícia Areas,
Ana Cristina Allemand Mancebo,
Marcelo Marinho de Souza,
Roberto de Azevedo Antunes,
María do Carmo Borges de Souza
Publication year - 2017
Publication title -
jbra
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 14
eISSN - 1518-0557
pISSN - 1517-5693
DOI - 10.5935/1518-0557.20170004
Subject(s) - luteolysis , controlled ovarian hyperstimulation , live birth , pregnancy , antagonist , basal (medicine) , pregnancy rate , stimulation , hormone antagonist , endometrium , abortion , medicine , embryo transfer , luteal phase , andrology , gynecology , biology , in vitro fertilisation , hormone , receptor , insulin , genetics
In controlled ovarian hyperstimulation (COH) using antagonist cycles, an incomplete luteolysis could happen after an inefficient previous luteolysis. Since antagonist cycles are frequent today, this study aims to access the impact of serum progesterone in the beginning and at the end of stimulation, and pregnancy outcomes.